Association of Menopausal Vasomotor Symptom Severity with Sleep and Work Impairments: a US Survey Creator: Open Health Communications / Astellas Pharma Inc. Duration: 4:36 Menopause Menopause. 30(9):887-897, September 2023 Show More Show Less This video is to present results of an online survey published in Menopause. The survey explores the association of vasomotor symptom severity with sleep quality and work productivity in perimenopausal and postmenopausal women in the US. Play Favorite
Endometrial Safety of Low-Dose Vaginal Estrogens Creator: Rachel Mandelbaum Duration: 2:04 Menopause Menopause. 30(6):650-658, June 2023 Show More Show Less In this commentary on low-dose vaginal estrogens, we review 30 years of data on endometrial safety as well as estrogen metabolism, receptor-binding, and actions in the vagina and endometrium. Play Favorite
Menopause Hormone Therapy and Urinary Symptoms: A Systematic Review Creator: UChicago Medicine Department of Obstetrics & Gynecology Duration: 3:22 Menopause Menopause. 30(6):672-685, June 2023 Show More Show Less We aimed to define the relationship between menopause and urinary symptoms including dysuria, urgency, recurrent urinary tract infections (UTIs), and urge and stress incontinence by conducting a systematic review of the effects of hormone therapy (HT) for urinary symptoms in peri- and post-menopausal women. At the conclusion of the review, we found that 1) there is insufficient evidence to confirm that menopause is associated with urinary symptoms, 2) the effect of HT on urinary symptoms depends on type, 3) systemic HT may cause urinary incontinence or worsen existing symptoms, and 4) vaginal estrogen improves dysuria, frequency, urge and stress incontinence, and recurrent UTIs in menopausal women. Play Favorite
Behavioral interventions for improving sleep outcomes in menopausal women: a systematic review and meta-analysis Creator: Christine Lam Duration: 3:08 Menopause Menopause. 29(10):1210-1221, October 2022 Show More Show Less Christine Lam provides a video summary of the paper entitled, “Behavioral interventions for improving sleep outcomes in menopausal women: a systematic review and meta-analysis.” She discusses the results, significance, and future research directions of the study which aimed to review the safety and efficacy of behavioral interventions for menopause-related sleep issues. Play Favorite
Is the cognitive performance of women sensitive to the severity of menopausal symptoms? Creator: Mankamal Kaur Duration: 4:54 Menopause Menopause. 29(2):170-177, February 2022 Show More Show Less The video summarizes the statistical methods used and the major findings of the research article entitled ‘Is the cognitive performance of women sensitive to the severity of menopausal symptoms?’. The clinical implications of the current research has also been discussed in the video. Play Favorite
Barriers to hormone therapy in BRCA1/2 mutation carriers Creator: Jessica DiSilvestro, MD Duration: 4:29 Menopause Menopause. 30(7):732-737, July 2023 Show More Show Less In this video, we review our recent manuscript on barriers to hormone therapy use after a prophylactic salpingo-oophorectomy in BRCA1/2 mutation carriers. Play Favorite
Dietary Intervention for Vasomotor Symptoms of Menopause Creator: Physicians Committee for Responsible Medicin Duration: 4:41 Menopause Menopause. 30(1):80-87, January 2023 Show More Show Less In a randomized study, a dietary intervention for menopausal hot flashes was tested. The diet was vegan and low in fat and included daily soybeans. The main result was an 88% reduction in moderate-to-severe hot flashes in 12 weeks. In this summary video, the principal investigator presents the findings, and several participants share their experiences. Play Favorite
Weight regulation in menopause Creator: Dr. Michael G. Knight Duration: 2:38 Menopause Menopause. 28(8):960-965, August 2021 Show More Show Less Obesity is an epidemic that affects post-menopausal women at increased rates. This review discusses the physiology, assessment, and effective treatment strategies for the treatment of obesity in this population. Play Favorite
Dyspareunia treatment with Erbium Laser in Breast Cancer Survivors Creator: Adrian Gaspar / Marco Gambacciani Duration: 4:19 Menopause Menopause. 30(2):174-178, February 2023 Show More Show Less The video explains the gist of the research: the innovative Hyperstack laser mode with non-ablative Erbium laser to treat superficial dyspareunia due to severe atrophy in breast cancer patients. Play Favorite
Type 1, Type 2 and Gestational Diabetes’ association with Age at Natural Menopaus Creator: Vrati M. Mehra Duration: 3:17 Menopause Menopause. 30(1):37-44, January 2023 Show More Show Less This is a video summary to accompany paper titled “The association between diabetes type, age of onset, and age at natural menopause: a retrospective cohort study using the Canadian Longitudinal Study on Aging”. The results of the study highlight that an earlier diagnosis of Type 1 Diabetes and Type 2 Diabetes is associated with earlier age at natural menopause. It was also found that a later age of diagnosis of diabetes is associated with a later age at natural menopause. No association was observed between gestational diabetes and age at natural menopause. Play Favorite
Ultrasound treatment for vaginal dryness Creator: Mindy Goldman Duration: 5:57 Menopause Menopause. 30(4):383-392, April 2023 Show More Show Less The therapeutic ultrasound device was developed for post-menopausal women with vulvovaginal atrophy who have refused or are not candidates for first-line or hormone therapy and could offer a satisfactory, long-term alternative for the treatment of vaginal symptoms. Play Favorite
The Severity of Vasomotor Symptoms and Number of Menopausal Symptoms in Postmenopausal Women and Select Clinical Health Outcomes in the Women's Health Initiative Calcium and Vitamin D Randomized Clinical Trial Creator: Peter Schnatz, Matthew Nudy, Darryl Bickell Duration: 4:52 Menopause Menopause. 27(11):1265-1273, November 2020 Show More Show Less This video summarizes the research article published in Menopause entitled “The severity of vasomotor symptoms and number of menopausal symptoms in postmenopausal women and select clinical health outcomes in the Women's Health Initiative Calcium and Vitamin D Randomized Clinical Trial”. Peter Schnatz and Matthew Nudy discuss the study design, menopausal symptoms recorded, outcomes assessed and the results. Having more moderate and severe menopausal symptoms was associated with increased cardiovascular disease and stroke. In addition, the clinical significance of the results are discussed. Play Favorite
Applying the MAUDE Database for Novel Technologies in Gynecology: Characterization of adverse events of vaginal energy-based devices Creator: Shannon Leigh Wallace Duration: 5:24 Menopause Menopause. 28(2):135-141, February 2021 Show More Show Less This video describes how our group at Stanford accessed the publicly available MAUDE database to characterize the adverse events reports of vaginal energy-based devices. In this video we discuss the recent FDA announcement released on July 30, 2018 regarding vaginal energy-based devices. Play Favorite
Improving the Identification of Genitourinary Syndrome of Menopause through the Utilization of the Day-to-Day Impact of Vaginal Aging Questionnaire Creator: Jennie Mastroianni, DNP Duration: 5:18 Menopause Menopause. 27(11):1295-1301, November 2020 Show More Show Less Genitourinary syndrome of menopause (GSM) affects nearly 50% of postmenopausal women. Yet, it is a problem that is difficult for both providers and patients to discuss—particularly the impact of GSM symptoms on a women’s daily activities. This quality improvement project implemented the Day-to-Day Impact of Vaginal Aging (DIVA) questionnaire to improve the identification and diagnosis of GSM. Our findings support the use of the DIVA questionnaire as an efficient tool in a busy women’s health practice setting to facilitate GSM identification and diagnosis. Play Favorite
Psychological Well-Being of Midlife Women Creator: Jiwon Lee, PhD Duration: 4:01 Menopause Menopause. 29(4):440-449, April 2022 Show More Show Less This study used a structural equation model to test the significance of factors associated with the psychological well-being of midlife women in South Korea based on the transactional model of stress and coping. Self-efficacy (exogenous variable) was positively associated with the psychological well-being (endogenous variable) of middle-aged women and appeared to be mediated by perceived stress, menopausal management, menopausal symptoms, and self-compassion. The predictor variables had an explanatory power of 79.5% for psychological well-being. These results can be helpful in the future development of interventions to improve psychological well-being by improving self-efficacy and coping with stress in middle-aged women. Play Favorite
Migraine and Sleep Quality: Does the Association Change in Midlife Women Creator: Summer Ghaith Duration: 5:15 Menopause Menopause. 30(4):376-382, April 2023 Show More Show Less migraine, menopause, sleep, sleep quality, midlife women Play Favorite
Metabolic effects of menopause: a cross-sectional characterization of body composition and exercise metabolism Creator: Duration: 5:16 Menopause Menopause. 29(4):377-389, April 2022 Show More Show Less This video is a summary of the manuscript titled ‘Metabolic effects of menopause: a cross-sectional characterization of body composition and exercise metabolism.’ The video discusses briefly the background, purpose, results, and conclusions of this study. Peri-menopause may be the optimal window for intervention, and these women should aim to prevent losses of fat-free mass and decrements in metabolism by participating in resistance and high-intensity exercise. Play Favorite
Genitourinary syndrome of menopause: A systematic review on prevalence and treatment Creator: Nikoletta Mili Duration: 6:03 Menopause Menopause. 28(6):706-716, June 2021 Show More Show Less Video summary of the article entitled “Genitourinary syndrome of menopause: A systematic review on prevalence and treatment”. This article aimed to systematically review the literature to investigate the prevalence of GSM and its treatment. GSM is a highly prevalent condition among women. Nevertheless, women are frequently not aware of its cause and its treatment options. The findings of this review underline the need for education of patients and health care professionals regarding GSM diagnosis and treatment options. Play Favorite
Anti-Mullerian Hormone and adiposity in mid-life among women in Project Viva Creator: Ellen C. Francis Duration: 2:59 Menopause Menopause. 30(3):247-253, March 2023 Show More Show Less Summary of findings from Project Viva. In a longitudinal cohort from Massachusetts, anti-Mullerian Hormone below 1 ng/ml at mid-reproductive age was associated with higher average weight, BMI, and waist circumference across ~9 years of subsequent follow-up. Play Favorite
Patient reported sexual function of breast cancer survivors with genitourinary syndrome of menopause after CO2 laser therapy Creator: Allison Quick Duration: 3:00 Menopause Menopause. 28(6):642-649, June 2021 Show More Show Less This video is conducted by first author, Allison Quick, on a single arm prospective study of fractional CO2 laser therapy for breast cancer survivors. The study evaluates changes in sexual function questionnaires from baseline to 4 weeks and 12 months after treatment. Play Favorite
The Seasonal Effects on Menopause Symptoms Subscriber Access Only Creator: Brian Lillie Duration: 4:10 Menopause January 2020, Volume 27, Issue 1; Menopause. 27(1):5-13, January 2020 Show More Show Less Sioban Harlow, professor of epidemiology and global public health and director of the Center for Midlife Science at the University of Michigan School of Public Health, explains findings from a study published in the July 2019 issue of the journal Menopause on the impact of season and proximity to the final menstrual period on common menopausal symptoms, including hot flashes, night sweats and trouble sleeping. Play Favorite
Self-reported menstrual cycle length during reproductive years in relation to menopausal symptoms at midlife in Project Viva Creator: Lidia Minguez-Alarcon Duration: 3:43 Menopause Menopause. 29(10):1130-1136, October 2022 Show More Show Less This video is a summary of the accepted manuscript in Menopause. Play Favorite
Validation of the Menopause Transition Scale (MTS) Creator: Missy Richeal, Leverage Marketing Duration: 4:32 Menopause Show More Show Less The MTS is a thorough patient-centric survey to measure symptoms of menopause as women transition in the outpatient setting. Play Favorite
Efficacy of progesterone-only treatment for the management of menopausal symptoms: A systematic review Creator: Sarah Sheehan Stadler, MD Duration: 3:51 Menopause Menopause. 28(2):217-224, February 2021 Show More Show Less Review of literature regarding progesterone only for the management of menopausal symptoms Play Favorite
Validation of the CBT-Meno Protocol: A summary of a recent RCT Creator: Eleanor Donegan, Ph.D., C.Psych. Duration: 3:03 Menopause Menopause. 26(9):972-980, September 2019 Show More Show Less The menopausal transition is associated with a number of adverse changes for many women, including vasomotor and depressive symptoms, anxiety, poor sleep, urogenital and sexual concerns. Pharmacotherapy is effective but can be associated with health-related concerns for some women and there is a need for non-pharmacological interventions that target a range of menopausal symptoms. Our research group developed a new cognitive behavioral therapy protocol (CBT-Meno) to target a range of commonly-reported menopausal symptoms. In this video, we summarize the results of a recent randomized controlled trial evaluating the effectiveness of the CBT-Meno protocol compared to a waitlist condition. Play Favorite
Equol and Obesity Creator: Atsushi Takahashi Duration: 3:28 Menopause Menopause. 28(7):807-810, July 2021 Show More Show Less In this video, Dr. Takahashi provides a summary of article “Association of equol with obesity in postmenopausal women.” Play Favorite
Interaction between postmenopausal hormone therapy and diabetes on cataract. Creator: Christy Costanian Duration: 3:36 Menopause Menopause. 27(3):263-268, March 2020 Show More Show Less The purpose of this study was to investigate whether postmenopausal hormone therapy (HT) use interacts with diabetes, a risk factor for several age-related eye diseases. The study found that long-term HT use and type 2 diabetes interact in their relationship with cataract such that the odds of cataract is highest in that group. Play Favorite
Are women still sexually active after menopause? Creator: Sussex Health Outcomes Research & Education in Cancer; filmed and edited by Matt Bemment, Communication Assistant, Brighton and Sussex Medical School Duration: 4:35 Menopause Menopause. 26(10):1100-1009, October 2019 Show More Show Less What do we really know about sex after menopause? This video summary reports on the results of a free-text analysis on sexual activity in over 4,400 postmenopausal women who took part in UKCTOCS, a large UK ovarian cancer screening trial. It shows that sexuality can change when we get older and that relationship status and health have a direct effect on sexuality and satisfaction. We believe it is important to raise awareness among women and healthcare professionals to increase the understanding of sexual issues women may face in later life. Play Favorite
Hormone therapy in menopausal women with hypothyroidism Creator: Juliana Kaminski Duration: 3:17 Menopause Menopause. 28(9):1044-1052, September 2021 Show More Show Less This video describes the rationale for our study and briefly summarizes the findings Play Favorite
Effects of heavy metal, vitamin, and curry consumption on metabolic syndrome during menopause: a Korean community-based cross-sectional study Creator: Min Sun Kim Hai Nguyen Duc Duration: 4:55 Menopause Menopause. 28(8):949-959, August 2021 Show More Show Less Our research aims to determine the associations between metabolic syndrome (MetS), serum heavy metal levels, vitamin and curry rice consumption during menopause.> As it is known, over the last few decades the consumption of high-fat, saturated, high energy diets, alcohol consumption, and smoking have increased in South Korea. These lifestyle changes have resulted in a rapid increase in the prevalence of metabolic syndrome (MetS). Of note, the prevalence of MetS has increased more rapidly in women than in men due to the effects of aging and estrogen loss in menopause. Growing evidence indicates heavy metals are a risk factor for MetS. Unfortunately, rapid industrialization and urbanization have increased heavy metal exposure. Recent research has increased understanding of the impact of diet on MetS. For example, it has been established that daily vitamin intake and vegetable and fruit consumption reduce MetS risk in the general population. Curried rice is a popular food in Korea and contains a high concentration of curcumin, which is helpful for preventing and/or treating MetS because of its anti-oxidant and anti-inflammatory properties. A data set of 7,131 pre- and post-menopausal women aged ≥ 20 years collected between 2009 and 2017 was used to obtain information on sociodemographic, lifestyles, family histories, food intakes, and serum heavy metal levels, and MetS. Our results show that: Postmenopausal women had a higher risk of MetS than premenopausal women. During post-menopause: Cadmium exposure increased the risk of MetS. Elevated Hb levels were found to be positively associated with the prevalence of MetS, which suggests that Hb might be useful clinically to evaluate body iron status during menopause. Our findings show higher HbA1c levels are associated with a significantly higher risk of MetS development during menopause. These results suggest that HbA1c levels might be a predictive clinical biomarker of MetS, insulin resistance, and type 2 diabetes during menopause. High curry consumption reduced the risk of MetS significantly more than low curry consumption in premenopausal women. Furthermore, an increase in daily vitamin B2 intake by one mg reduced the risk of MetS by 45% in postmenopausal women.Vitamin B2 and curry supplementation may protect against MetS. However, the cross-sectional design of the study prevented evaluations of causality between MetS, heavy metals, vitamin, and curry intakes. Further work is needed to reduce risk factors associated with heavy metals and to determine the effects of vitamins and curry consumption on MetS during menopause. Play Favorite
Perimenopausal vasomotor symptoms and the cortisol awakening response Creator: Jennifer Gordon Duration: 3:45 Menopause Menopause. 27(11):1322-1327, November 2020 Show More Show Less Summary of “Perimenopausal vasomotor symptoms and the cortisol awakening response” Play Favorite
The Women’s Study for the Alleviation of Vasomotor Symptoms (WAVS) Creator: Physicians Committee for Responsible Medicine Duration: 4:44 Menopause Menopause. 28(10):1150-1156, October 2021 Show More Show Less Author of the Women’s Study for the Alleviation of Vasomotor Symptoms (WAVS), Neal Barnard, MD, FACC, and WAVS study participants, discuss how eating a plant-based diet, which includes soybeans, can reduce the severity and frequency of hot flashes. Play Favorite
Positive impact of a co-designed digital resource for women with early menopause Creator: Clinical Associate Professor Amanda Vincent, Monash Centre for Health Research and Implementation, Monash University, Melbourne Australia Duration: 4:17 Menopause Menopause. 29(6):671-679, June 2022 Show More Show Less Early menopause, defined as menopause before age 45 years, affects up to 12% of women. This video summarizes a study evaluating the first co-designed digital resource (www.healthtalkaustralia.org) specifically for women with early menopause. Play Favorite
Acupuncture ameliorated vasomotor symptoms during menopausal transition: single-blind, placebo-controlled, randomized trial to test treatment efficacy. Creator: José Maria Soares Júnior Duration: 6:30 Menopause Menopause. 28(1):80-85, January 2021 Show More Show Less 1) Introduction and Significance of manuscript; 2) Innovation of study; 3) Clinical application; 4) Strengths and limitations; 5) Application of technique on the diary practice; 6) conclusion of study Play Favorite
Use of exogenous hormones in those at increased risk for breast cancer: Contraceptive and menopausal hormones in gene carriers and other high-risk patients Creator: Holly J. Pederson MD Duration: 4:27 Menopause Menopause. 30(3):341-347, March 2023 Show More Show Less The video describes the four sections of the narrative review, proposing conclusions based on the data regarding hormonal contraception in highly penetrant gene mutation carriers from the BRCA literature, and hormonal contraception in other patients at increased risk for breast cancer. The two other sections describe menopausal hormone therapy in gene carriers and in other high-risk patients. Play Favorite
The RCT of vaginal CO2 laser in treating vaginal atrophy Creator: Purim Ruanphoo, MD. Duration: 3:06 Menopause Menopause. 27(8):858-863, August 2020 Show More Show Less Introduction to the RCT of vaginal CO2 laser and sham procedure in treating vaginal atrophy. Play Favorite
Visual Assessment of Genital Health in Menopausal Women Creator: Irwin Goldstein, MD Duration: 3:48 Menopause Menopause. 26(9):994-1001, September 2019 Show More Show Less This is a phase 3 pivotal trial of ospemifene versus placebo in women in menopause with moderate to severe vaginal dryness, a symptom of GSM. On physical examination, such women commonly have vulvar, vestibular and vaginal atrophy. This study, for the first time, utilized vulvar vestibular photography to objectively document changes in genital health. There were no changes noted in photography on placebo, however active therapy with a SERM resulted in regrowth of labia minora, normalization of the urethral gland prominence, resolution of the pallor and erythema of the vestibule and visualization of vestibular moisture. Visual assessment of genital health in such patients should be utilized in future trials. Play Favorite
Uterine Fibroids in Menopause and Perimenopause Creator: Paige WynneVideo Production SpecialistCreative and Digital Services University of Illinois at Chicago Duration: 3:34 Menopause February 2020, Volume 27, Issue 2; Menopause. 27(2):238-242, February 2020 Show More Show Less In this video, we glimpse the significance of Uterine fibroid disease and highlights their unusual persistence in menopause women. Moreover, we discuss the possible available treatment options as well as the advantages and disadvantages of using hormonal therapy in this specific population. Play Favorite
